Norman Maldonado
Hematology & Oncology · San Juan, PRNPI 1972564367
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 25.0% of the total. Reporting peaked in 2019 at $1,293 and has fallen 90.3% since, to $125 in 2023. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 105 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$525
- Merck$246
- PBG Puerto Rico LLC$229
- AbbVie$141
- Genentech USA, Inc.$123
- Bristol Myers Squibb$122
- plus $717 from 14 others
What the payments were for
- Food & beverage$2,04397%
- Education$603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 26 | $525 |
| Merck | 14 | $246 |
| PBG Puerto Rico LLC | 11 | $229 |
| AbbVie | 6 | $141 |
| Genentech USA, Inc. | 7 | $123 |
| Bristol Myers Squibb | 4 | $122 |
| Amgen | 6 | $105 |
| Johnson & Johnson(2 entities) | 3 | $93 |
| Taiho Oncology, Inc. | 4 | $80 |
| Novartis | 3 | $68 |
| Incyte Corporation | 3 | $60 |
| Sanofi | 3 | $53 |
| AstraZeneca | 3 | $53 |
| Pfizer Pharmaceuticals LLC | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $38 |
| Bayer | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
How this compares
$2,103 in reported general payments places this provider in the 20th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 16 | $154 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in San Juan
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Edgardo Santiago-GuzmanSan Juan$79K
- Adelba Torres-LopezSan Juan$73K
- Karla Feliciano SalvaSan Juan$44K
- Luis Delgado MateuSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.